The medical division of the industrial conglomerate Siemens (Berlin and Munich, Germany) has completed its purchase of Bayer Healthcare’s diagnostic division and merged it with Diagnostic Products Corporation (DPC), which Siemens Medical Solutions acquired last July, to create Siemens Medical Solutions Diagnostics. The new entity is headquartered in Tarrytown, New York, and Los Angeles, California, and has approximately 8,000 employees. The business will be led by CEO Anthony Bihl, who previously served as president of Bayer’s diagnostics division.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

February 2007 - Table of Contents

DTTR February 2007 (full PDF issue)

Siemens, GE Build Diagnostic Powerhouses

FDA to Hold Meeting on IVDMIA Draft Guidance

Pfizer Buys Diagnostic Rights for Genizon’s Disease Markers

New ACOG Guidelines Urge Earlier Screening for Down Syndrome

FDA Approves Ortho-Clinical’s Chagas Disease Screening Test

Initiative Seeks Routine SCID Screening for Newborns

Genomic Health Gets United, Aetna Reimbursement for Oncotype DX

Pharmacogenomics: Are Labs Believing the Hype?

JAMA Study Links Expanded Medicare Reimbursement With Increased Colon Cancer Screening, Earlier Diagnosis

Epigenomics Chooses New CEO, Contracts With Centocor for Cancer Biomarkers

Luminex to Buy Tm Bioscience for $37.9M

BD Closes on $350m TriPath Acquisition

IVD Stocks Rose 20% in 2006 Led by Immucor, Cholestech, Digene

Molecular Diagnostics: The Conference